ABBOTT LABORATORIES — Director's Dealing 2021

Feb 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-02-19

Reporting Person: LANE ANDREW H (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-19	Option (right to buy)	$124.04	A	71070	Acquired	2031-02-18	Common Shares (71070)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,690 on February 19, 2022, 23,690 on February 19, 2023, and 23,690 on February 19, 2024.